Biogen Inc. buy Needham & Company LLC
Start price
11.04.23
/
50%
€257.80
Target price
11.04.24
€297.70
Performance (%)
-26.01%
End price
12.04.24
€190.75
Summary
This prediction ended on 12.04.24 with a price of €190.75. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -26.01%. Needham___Company_LL has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Biogen Inc. | -2.983% | -2.983% | -30.846% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
Comments by Needham___Company_LL for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $325.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten